Who are the 10 key players in the $226B spine biologics market?

The global spine biologics market is projected to grow at a 4.4 percent compound annual growth rate, from $226 billion in 2018 to $280 billion by 2023, according to a Market Data Forecast report.

Advertisement

Here are the top 10 players in the market:

1. Alphatec Holdings

2. DePuy Synthes

3. Exactech

4. Globus Medical

5. Medtronic

6. NuVasive

7. Orthofix

8. RTI Surgical

9. SeaSpine

10. Zimmer Biomet

More articles on biologics:

206 Ortho gets bio-inspired patent: 3 quick notes

Emory Orthopaedics & Spine Center receives $13M to study stem cell osteoarthritis treatments: 4 notes

Bone Biologics raises $5.9M: 3 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.